These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 17342832

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Can single-patient investigational new drug studies hurry slow trains to the fast track?
    Chenoweth D.
    Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An audience with Tatiana Prowell. Interviewed by Asher Mullard.
    Prowell T.
    Nat Rev Drug Discov; 2014 Jun; 13(6):410-1. PubMed ID: 24875091
    [No Abstract] [Full Text] [Related]

  • 5. No way to save a life: allowing terminally ill patients access to drugs that have not completed clinical trials is a dangerous move.
    Moss RW.
    New Sci; 2014 Jun; 190(2554):21. PubMed ID: 16832956
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Food and Drug Administration requirements for approval of new anticancer drugs.
    Johnson JR, Temple R.
    Cancer Treat Rep; 1985 Oct; 69(10):1155-9. PubMed ID: 4042094
    [Abstract] [Full Text] [Related]

  • 12. [Drug development in paediatric oncology].
    Benninger-Döring G, Boos J.
    Klin Padiatr; 2006 Oct; 218(3):152-6. PubMed ID: 16688671
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cancer drug approval in the United States, Europe, and Japan.
    Milsted RA.
    Adv Cancer Res; 2007 Oct; 96():371-91. PubMed ID: 17161686
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expanded clinical trials of treatments for multiple sclerosis: copolymer 1 (COP-1) treatment investigational new drug (IND) program.
    Stark Y.
    Ann Neurol; 1994 Jul; 36(1):114-5. PubMed ID: 8024251
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.